Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target

Bladder cancer remains a prevalent and challenging malignancy. Myeloid-derived suppressor cells (MDSCs) have emerged as key contributors to the immunosuppressive tumor microenvironment, facilitating tumor progression, immune evasion, and resistance to therapies. This review explores the role of MDSC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Clément Klein, Samy Mebroukine, Mathilde Madéry, Alexandra Moisand, Thomas Boyer, Nicolas Larmonier, Grégoire Robert, Charlotte Domblides
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Series:	Cells
Subjects:	myeloid-derived suppressor cells bladder cancer tumor microenvironment immune inhibition biomarker immunotherapy
Online Access:	https://www.mdpi.com/2073-4409/13/21/1779
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)
by: Emma Keltsch, et al.
Published: (2025-07-01)

The effect of conditioned media on the cellular proliferation of pancreatic cancer cells, pancreatic stellate cells, and myeloid-derived suppressor cells
by: Y. Chong, et al.
Published: (2025-01-01)

The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)

The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
by: Chengyuan Li, et al.
Published: (2025-02-01)

Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations
by: Tianying Hu, et al.
Published: (2025-06-01)

EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment
by: Tian Xia, et al.
Published: (2024-12-01)

The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)

Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
by: Shin Young Hyun, et al.
Published: (2020-10-01)

Myeloid-derived suppressor-like cells - does their frequency change in patients with different stages of CRC?
by: Brčerević Irina, et al.
Published: (2023-01-01)

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation
by: Chunxiao Li, et al.
Published: (2025-01-01)

Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection
by: JOYCE C. GUIMARÃES-DE-OLIVEIRA, et al.
Published: (2025-04-01)

A novel method for isolation of tumor infiltrating myeloid-derived suppressor cells from human lung tumor tissue
by: Marta Piqueras-Nebot, et al.
Published: (2025-04-01)

Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
by: Xin Xiong, et al.
Published: (2023-06-01)

High-resolution transcriptome atlas of bladder cancer highlights the functional myeloid subsets in modulating immune microenvironmentResearch in context
by: Jiachen Liu, et al.
Published: (2025-07-01)

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
by: Nilesh U. Deshpande, et al.
Published: (2025-06-01)

High Humidity Alters Myeloid-Derived Suppressor Cells in Spleen Tissue: Insights into Rheumatoid Arthritis Progression
by: Wang H, et al.
Published: (2024-11-01)

Abnormal proportions and functions of myeloid-derived suppressor cells in peripheral blood of patients with diffuse large B-cell lymphoma
by: Jingru Liu, et al.
Published: (2025-04-01)

Tumor suppressor genes in the tumor microenvironment
by: Bahareh Tabanifar, et al.
Published: (2025-03-01)

PKN2 enhances the immunosuppressive activity of polymorphonuclear myeloid-derived suppressor cells in esophageal carcinoma by mediating fatty acid oxidation
by: Xiao Fu, et al.
Published: (2025-03-01)

Myeloid-derived suppressor cells in axial spondyloarthritis patients with different types of therapy
by: A. Yu. Morenkova, et al.
Published: (2024-06-01)

HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
by: Zhiqi Xie, et al.
Published: (2025-02-01)

Myeloid-derived suppressor cells in multiple myeloma patients at the immune recovery and after high-dose chemotherapy and hematopoietic stem cell transplantation
by: T. V. Tyrinova, et al.
Published: (2023-01-01)

Impact of Reduction in Myeloid‐derived Suppressor Cells by Wilms’ Tumor 1‐targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients
by: Masahiro Ogasawara, et al.
Published: (2025-06-01)

Caspase‐6/Gasdermin C‐Mediated Tumor Cell Pyroptosis Promotes Colorectal Cancer Progression Through CXCL2‐Dependent Recruitment of Myeloid‐Derived Suppressor Cells
by: Hanchao Gao, et al.
Published: (2025-05-01)

Do nature of bacteremia and origin of secondary sepsis in critically ill patients determine subset of myeloid-derived suppressor cells expansion?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy
by: Nada Mohamady Farouk Abdalsalam, et al.
Published: (2024-11-01)

Association of myeloid-derived suppressor cells with hematopoietic recovery after high-dose chemotherapy in multiple myeloma
by: V. S. Anmut, et al.
Published: (2023-06-01)

Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis
by: Dušan Radojević, et al.
Published: (2022-12-01)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
by: Jingwei Jiang, et al.
Published: (2018-09-01)

Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach
by: Fuyang Liu, et al.
Published: (2025-05-01)

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
by: Christin Knickmeier, et al.
Published: (2025-01-01)

Significance of myeloid-derived suppressor cells (MDSCs) like CD14+B7-H4 cells frequency in blood and tumor microcirculation of lung cancer patients
by: Vuković Jelena, et al.
Published: (2021-01-01)

Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
by: Anna Di Spirito, et al.
Published: (2025-03-01)

Effect of pregnancy-specific β1-glycoprotein on myeloid-derived suppressor cell differentiation
by: V. P. Timganova, et al.
Published: (2023-06-01)

Pre-treatment monocytic myeloid-derived suppressor cells as predictive biomarkers for immune checkpoint inhibitor response in clear cell renal cell carcinoma
by: Yiming Jin, et al.
Published: (2025-08-01)

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
by: C. D’Alterio, et al.
Published: (2025-04-01)

Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer
by: Erin M. Dickey, et al.
Published: (2024-12-01)

FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
by: Maxim Noeraparast, et al.
Published: (2024-10-01)